$CapsoVision, Inc.(CV)$-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
Comment
Favorite

JagdeepSingh
07-03

$CapsoVision, Inc.(CV)$

Stock Track | CapsoVision (CV) Soars 6.90% in Debut Trading Following $27.5 Million IPO

Shares of CapsoVision, Inc. are soaring 6.90% in intraday trading on Wednesday, marking a strong debut for the medical technology company following its initial public offering . The surge comes after CapsoVision priced its IPO at $5 per share, aiming to raise approximately $27.5 million in gross proceeds.CapsoVision offered 5.5 million shares in its IPO, which was priced late Tuesday. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares, potential

Stock Track | CapsoVision (CV) Soars 6.90% in Debut Trading Following $27.5 Million IPO

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":452402578841720,"tweetId":"452402578841720","gmtCreate":1751473390725,"gmtModify":1751473392582,"author":{"id":4203902996163222,"idStr":"4203902996163222","authorId":4203902996163222,"authorIdStr":"4203902996163222","name":"JagdeepSingh","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.08","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://ttm.financial/S/CV\">$CapsoVision, Inc.(CV)$ </a>&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://ttm.financial/S/CV\">$CapsoVision, Inc.(CV)$ </a>&nbsp;</p></body></html>","text":"$CapsoVision, Inc.(CV)$","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/452402578841720","repostId":1155676065,"repostType":2,"repost":{"id":"1155676065","kind":"news","weMediaInfo":{"introduction":"Track stock‘s movements and relevant news","home_visible":1,"media_name":"Stock Track","id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1751468304,"share":"https://ttm.financial/m/news/1155676065?lang=en_US&edition=fundamental","pubTime":"2025-07-02 22:58","market":"nz","language":"en","title":"Stock Track | CapsoVision (CV) Soars 6.90% in Debut Trading Following $27.5 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1155676065","media":"Stock Track","summary":"Shares of CapsoVision, Inc.  are soaring 6.90% in intraday trading on Wednesday, marking a strong debut for the medical technology company following its initial public offering . The surge comes after CapsoVision priced its IPO at $5 per share, aiming to raise approximately $27.5 million in gross proceeds.CapsoVision offered 5.5 million shares in its IPO, which was priced late Tuesday. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares, potential","content":"<p>Shares of CapsoVision, Inc. (CV) are soaring 6.90% in intraday trading on Wednesday, marking a strong debut for the medical technology company following its initial public offering (IPO). The surge comes after CapsoVision priced its IPO at $5 per share, aiming to raise approximately $27.5 million in gross proceeds.</p>\n\n<p>CapsoVision offered 5.5 million shares in its IPO, which was priced late Tuesday. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares, potentially increasing the total capital raised. Trading of CapsoVision shares on the Nasdaq under the ticker symbol \"CV\" commenced on Wednesday, with the offering expected to close on Thursday.</p>\n\n<p>The robust 6.90% gain in CapsoVision's stock price suggests strong investor interest in the medical technology sector and confidence in the company's potential. As a newly public company, CapsoVision's performance is being closely watched by market participants, with the successful IPO and positive first-day trading potentially setting a promising tone for the company's future in the public markets.</p>","source":"ai_movement_en","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CapsoVision (CV) Soars 6.90% in Debut Trading Following $27.5 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CapsoVision (CV) Soars 6.90% in Debut Trading Following $27.5 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-07-02 22:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of CapsoVision, Inc. (CV) are soaring 6.90% in intraday trading on Wednesday, marking a strong debut for the medical technology company following its initial public offering (IPO). The surge comes after CapsoVision priced its IPO at $5 per share, aiming to raise approximately $27.5 million in gross proceeds.</p>\n\n<p>CapsoVision offered 5.5 million shares in its IPO, which was priced late Tuesday. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares, potentially increasing the total capital raised. Trading of CapsoVision shares on the Nasdaq under the ticker symbol \"CV\" commenced on Wednesday, with the offering expected to close on Thursday.</p>\n\n<p>The robust 6.90% gain in CapsoVision's stock price suggests strong investor interest in the medical technology sector and confidence in the company's potential. As a newly public company, CapsoVision's performance is being closely watched by market participants, with the successful IPO and positive first-day trading potentially setting a promising tone for the company's future in the public markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CV":"CapsoVision, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155676065","content_text":"Shares of CapsoVision, Inc. (CV) are soaring 6.90% in intraday trading on Wednesday, marking a strong debut for the medical technology company following its initial public offering (IPO). The surge comes after CapsoVision priced its IPO at $5 per share, aiming to raise approximately $27.5 million in gross proceeds.\nCapsoVision offered 5.5 million shares in its IPO, which was priced late Tuesday. The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares, potentially increasing the total capital raised. Trading of CapsoVision shares on the Nasdaq under the ticker symbol \"CV\" commenced on Wednesday, with the offering expected to close on Thursday.\nThe robust 6.90% gain in CapsoVision's stock price suggests strong investor interest in the medical technology sector and confidence in the company's potential. As a newly public company, CapsoVision's performance is being closely watched by market participants, with the successful IPO and positive first-day trading potentially setting a promising tone for the company's future in the public markets.","news_type":1,"symbols_score_info":{"CV":1}},"isVote":1,"tweetType":1,"viewCount":1009,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":22,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}